$13.86
00.00%
Pre-Market: 4:01 PM EDT
15 minutes delayed
Inhibrx Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Inhibrx Biosciences using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
INBX | Inhibrx | -$1.08 | — | — | — | $30.00K | — | — | — | 08/05/2024 | Get Alert |
INBX | Inhibrx | -$1.12 | -$1.51 | — | — | $17.00K | — | — | — | 07/30/2024 | Get Alert |
INBX | Inhibrx | -$0.95 | -$1.04 | -$1.73 | -66.35% | $274.00K | $50.00K | $1.63M | 3168.00% | 02/28/2024 | Get Alert |
INBX | Inhibrx | -$0.90 | -$1.01 | -$1.10 | -8.91% | $278.00K | — | $119.00K | — | 11/09/2023 | Get Alert |
INBX | Inhibrx | -$0.97 | -$1.03 | -$1.08 | -4.85% | $711.00K | — | $30.00K | — | 08/07/2023 | Get Alert |
INBX | Inhibrx | -$0.80 | -$0.84 | -$1.12 | -33.33% | $929.00K | $150.00K | $17.00K | -88.67% | 05/08/2023 | Get Alert |
INBX | Inhibrx | -$0.55 | -$0.79 | -$0.95 | -20.25% | $2.86M | $790.00K | $274.00K | -65.32% | 03/06/2023 | Get Alert |
INBX | Inhibrx | -$0.54 | -$0.94 | -$0.90 | 4.26% | $2.53M | $630.00K | $278.00K | -55.87% | 11/07/2022 | Get Alert |
INBX | Inhibrx | -$0.55 | -$0.78 | -$0.97 | -24.36% | $954.00K | $1.07M | $711.00K | -33.55% | 08/08/2022 | Get Alert |
INBX | Inhibrx | -$0.51 | — | -$0.80 | — | $889.00K | — | $929.00K | — | 05/09/2022 | Get Alert |
INBX | Inhibrx | -$0.47 | — | -$0.55 | — | $2.78M | — | $2.86M | — | 02/28/2022 | Get Alert |
INBX | Inhibrx | -$0.77 | -$0.57 | -$0.54 | 5.26% | $5.90M | $1.00M | $2.53M | 153.20% | 11/09/2021 | Get Alert |
INBX | Inhibrx | -$0.99 | -$0.56 | -$0.55 | 1.79% | — | $820.00K | $954.00K | 16.34% | 08/09/2021 | Get Alert |
INBX | Inhibrx | -$1.11 | -$0.56 | -$0.51 | 8.93% | — | $920.00K | $889.00K | -3.37% | 05/13/2021 | Get Alert |
INBX | Inhibrx | — | — | -$0.47 | — | — | — | $2.78M | — | 03/12/2021 | Get Alert |
INBX | Inhibrx | -$1.11 | -$0.60 | -$0.77 | -28.33% | $1.22M | $1.00M | $5.90M | 490.10% | 11/13/2020 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Dec 2023 | 2024-02-28 | $-1.73 | $-1.04 | -66.3 % |
Sep 2023 | 2023-11-09 | $-1.10 | $-1.01 | -8.91 % |
Jun 2023 | 2023-08-07 | $-1.08 | $-1.03 | -4.85 % |
Mar 2023 | 2023-05-08 | $-1.12 | $-0.84 | -33.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Dec 2023 | 2024-02-28 | $1.63M | $50.00K | 3168.0 % |
Mar 2023 | 2023-05-08 | $17.00K | $150.00K | -88.7 % |
Dec 2022 | 2023-03-06 | $274.00K | $790.00K | -65.3 % |
Sep 2022 | 2022-11-07 | $278.00K | $630.00K | -55.9 % |
Inhibrx Biosciences (INBX) is scheduled to report earnings on August 5, 2024. The last reported earnings were for reported on February 28, 2024 for Q4.
The Actual EPS was $-1.73, which missed the estimate of $-1.04.
The Actual Revenue was $1.6M, which beat the estimate of $50K.
Browse earnings estimates, EPS, and revenue on all stocks.